In particular, a statistically significant association was found between CHEK1, MAP2K1, and PLK1 overexpression and worse overall survival in breast invasive carcinoma patients, indicated by pooled hazard ratio (HR) values higher than 1 and p-values lower than 0.05. This evidence concerns the gene CHEK1 and invasive breast carcinoma.